FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,506,186 | -14.9% | 466,869 | 0.0% | 2.56% | +10.9% |
| Q2 2023 | $4,122,453 | +6.1% | 466,869 | 0.0% | 2.31% | -10.0% |
| Q1 2023 | $3,884,350 | +27.7% | 466,869 | +47.3% | 2.57% | +5.3% |
| Q4 2022 | $3,042,710 | +98.0% | 316,949 | +67.0% | 2.44% | +198.8% |
| Q3 2022 | $1,537,000 | +45.1% | 189,750 | 0.0% | 0.82% | +58.4% |
| Q2 2022 | $1,059,000 | -0.4% | 189,750 | 0.0% | 0.52% | +15.5% |
| Q1 2022 | $1,063,000 | +27.3% | 189,750 | 0.0% | 0.45% | +112.4% |
| Q4 2021 | $835,000 | -49.3% | 189,750 | +8.6% | 0.21% | -64.0% |
| Q3 2021 | $1,646,000 | +86.8% | 174,750 | +44.6% | 0.58% | +18.7% |
| Q2 2021 | $881,000 | – | 120,851 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 867,857 | $6,327,000 | 4.44% |
| Sonic Fund II, L.P. | 2,433,230 | $17,738,000 | 1.31% |
| DG Capital Management, LLC | 588,773 | $4,292,000 | 0.93% |
| Southpoint Capital Advisors LP | 4,077,214 | $29,723,000 | 0.52% |
| HARBERT FUND ADVISORS, INC. | 120,851 | $881,000 | 0.49% |
| 683 Capital Management, LLC | 1,110,000 | $8,091,000 | 0.28% |
| Avoro Capital Advisors LLC | 1,670,000 | $12,174,000 | 0.21% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $292,000 | 0.16% |
| Tibra Equities Europe Ltd | 46,300 | $338,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 68,724 | $501,000 | 0.06% |